A randomized trial of tenapanor and phosphate binders as a dual-mechanism treatment for hyperphosphatemia in patients on maintenance dialysis (AMPLIFY)
Journal of the American Society of Nephrology | Apr 01, 2021
Ambulatory treatments for RAAS inhibitor-related hyperkalemia and the 1-year risk of recurrence
Clinical Journal of the American Society of Nephrology | Feb 25, 2021
Effect of phosphate-specific diet therapy on phosphate levels in adults undergoing maintenance hemodialysis: A systematic review and meta-analysis
Clinical Journal of the American Society of Nephrology | Jan 11, 2021
Most read this week